FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3112270200> ?p ?o ?g. }

• W3112270200 endingPage "e040123" @default.
• W3112270200 startingPage "e040123" @default.
• W3112270200 abstract "Introduction Success rates of psychotherapy in post-traumatic stress disorder related to childhood maltreatment (PTSD-CM) are limited. Methods and analysis Observer-blind multicentre randomised clinical trial (A-1) of 4-year duration comparing enhanced methods of STAIR Narrative Therapy (SNT) and of trauma-focused psychodynamic therapy (TF-PDT) each of up to 24 sessions with each other and a minimal attention waiting list in PTSD-CM. Primary outcome is severity of PTSD (Clinician-Administered PTSD Scale for DSM-5 total) assessed by masked raters. For SNT and TF-PDT, both superiority and non-inferiority will be tested. Intention-to-treat analysis (primary) and per-protocol analysis (secondary). Assessments at baseline, after 10 sessions, post-therapy/waiting period and at 6 and 12 months of follow-up. Adult patients of all sexes between 18 and 65 years with PTSD-CM will be included. Continuing stable medication is permitted. To be excluded: psychotic disorders, risk of suicide, ongoing abuse, acute substance related disorder, borderline personality disorder, dissociative identity disorder, organic mental disorder, severe medical conditions and concurrent psychotherapy. To be assessed for eligibility: n=600 patients, to be e randomly allocated to the study conditions: n=328. Data management, randomisation and monitoring will be performed by an independent European Clinical Research Infrastructure Network (ECRIN)-certified data coordinating centre for clinical trials (KKS Marburg). Report of AEs to a data monitoring and safety board. Complementing study A-1, four inter-related add-on projects, including subsamples of the treatment study A-1, will examine (1) treatment integrity (adherence and competence) and moderators and mediators of outcome (B-1); (2) biological parameters (B-2, eg, DNA damage, reactive oxygen species and telomere shortening); (3) structural and functional neural changes by neuroimaging (B-3) and (4) cost-effectiveness of the treatments (B-4, costs and utilities). Ethics and dissemination Approval by the institutional review board of the University of Giessen (AZ 168/19). Following the Consolidated Standards of Reporting Trials statement for non-pharmacological trials, results will be reported in peer-reviewed scientific journals and disseminated to patient organisations and media. Trial registration number DRKS 00021142." @default.
• W3112270200 created "2020-12-21" @default.
• W3112270200 creator A5001355206 @default.
• W3112270200 creator A5003856953 @default.
• W3112270200 creator A5011657531 @default.
• W3112270200 creator A5011959632 @default.
• W3112270200 creator A5012010929 @default.
• W3112270200 creator A5013509044 @default.
• W3112270200 creator A5017571346 @default.
• W3112270200 creator A5021437905 @default.
• W3112270200 creator A5028384182 @default.
• W3112270200 creator A5042015206 @default.
• W3112270200 creator A5048016826 @default.
• W3112270200 creator A5051290664 @default.
• W3112270200 creator A5056161829 @default.
• W3112270200 creator A5058523889 @default.
• W3112270200 creator A5063120397 @default.
• W3112270200 creator A5066522017 @default.
• W3112270200 creator A5069057930 @default.
• W3112270200 creator A5069886120 @default.
• W3112270200 creator A5070860197 @default.
• W3112270200 creator A5071346253 @default.
• W3112270200 creator A5074260546 @default.
• W3112270200 creator A5074721787 @default.
• W3112270200 creator A5079687505 @default.
• W3112270200 creator A5084455987 @default.
• W3112270200 creator A5086907081 @default.
• W3112270200 creator A5090648908 @default.
• W3112270200 date "2020-12-01" @default.
• W3112270200 modified "2023-10-03" @default.
• W3112270200 title "Trauma-focused psychodynamic therapy and STAIR Narrative Therapy of post-traumatic stress disorder related to childhood maltreatment: trial protocol of a multicentre randomised controlled trial assessing psychological, neurobiological and health economic outcomes (ENHANCE)" @default.
• W3112270200 cites W1529179780 @default.
• W3112270200 cites W1937705451 @default.
• W3112270200 cites W1942764124 @default.
• W3112270200 cites W1972270027 @default.
• W3112270200 cites W1972404351 @default.
• W3112270200 cites W1988299038 @default.
• W3112270200 cites W1994222210 @default.
• W3112270200 cites W1994950269 @default.
• W3112270200 cites W1997304215 @default.
• W3112270200 cites W1999477872 @default.
• W3112270200 cites W2000806250 @default.
• W3112270200 cites W2001976182 @default.
• W3112270200 cites W2015025583 @default.
• W3112270200 cites W2020740556 @default.
• W3112270200 cites W2037065143 @default.
• W3112270200 cites W2059034217 @default.
• W3112270200 cites W2060616731 @default.
• W3112270200 cites W2064291937 @default.
• W3112270200 cites W2072158327 @default.
• W3112270200 cites W2079579416 @default.
• W3112270200 cites W2088040467 @default.
• W3112270200 cites W2093982682 @default.
• W3112270200 cites W2101446476 @default.
• W3112270200 cites W2103299406 @default.
• W3112270200 cites W2108531476 @default.
• W3112270200 cites W2110491184 @default.
• W3112270200 cites W2111459052 @default.
• W3112270200 cites W2114364160 @default.
• W3112270200 cites W2120220100 @default.
• W3112270200 cites W2120575493 @default.
• W3112270200 cites W2123198963 @default.
• W3112270200 cites W2127089902 @default.
• W3112270200 cites W2137658464 @default.
• W3112270200 cites W2156083836 @default.
• W3112270200 cites W2160751359 @default.
• W3112270200 cites W2333576952 @default.
• W3112270200 cites W2473786944 @default.
• W3112270200 cites W2513332318 @default.
• W3112270200 cites W2548027169 @default.
• W3112270200 cites W2599805023 @default.
• W3112270200 cites W2659552866 @default.
• W3112270200 cites W2751288712 @default.
• W3112270200 cites W2787126648 @default.
• W3112270200 cites W2892364332 @default.
• W3112270200 cites W2914765137 @default.
• W3112270200 cites W2916316700 @default.
• W3112270200 cites W2945935519 @default.
• W3112270200 cites W4234974210 @default.
• W3112270200 cites W4239116709 @default.
• W3112270200 cites W4244453275 @default.
• W3112270200 cites W4246491026 @default.
• W3112270200 cites W4247348921 @default.
• W3112270200 cites W72858689 @default.
• W3112270200 doi "https://doi.org/10.1136/bmjopen-2020-040123" @default.
• W3112270200 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7747578" @default.
• W3112270200 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33334832" @default.
• W3112270200 hasPublicationYear "2020" @default.
• W3112270200 type Work @default.
• W3112270200 sameAs 3112270200 @default.
• W3112270200 citedByCount "3" @default.
• W3112270200 countsByYear W31122702002022 @default.
• W3112270200 countsByYear W31122702002023 @default.
• W3112270200 crossrefType "journal-article" @default.
• W3112270200 hasAuthorship W3112270200A5001355206 @default.
• W3112270200 hasAuthorship W3112270200A5003856953 @default.
• W3112270200 hasAuthorship W3112270200A5011657531 @default.
• W3112270200 hasAuthorship W3112270200A5011959632 @default.

• next